Case-Based Learning on Persistent Fever With Unresolved Inflammatory Etiology: A Clinical Review

Abstract

Persistent fever with unresolved inflammatory etiology presents a significant diagnostic and therapeutic challenge in clinical practice. This article explores the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approach, and management strategies for patients with prolonged febrile illness of unknown origin, integrating recent evidence, guideline-based recommendations, and practical insights for clinicians. Emphasis is placed on case-based learning to enhance real-world applicability and improve patient outcomes.

Introduction

Fever of unknown origin (FUO) remains a complex clinical syndrome characterized by prolonged fever without an established diagnosis despite appropriate investigations. Persistent inflammatory fever often signals a wide spectrum of underlying pathologies, ranging from infections to autoimmune, neoplastic, and miscellaneous disorders. The diagnostic approach demands systematic reasoning, multidisciplinary input, and judicious use of resources. Case-based learning is invaluable in illustrating diagnostic nuances, evolving therapeutic paradigms, and fostering critical thinking among healthcare providers.

Epidemiology / Disease Burden

The prevalence of persistent fever with unresolved inflammatory etiology varies geographically and demographically. In developed countries, non-infectious inflammatory diseases now rival infections as leading causes of FUO, while infections predominate in resource-limited settings. Up to 30% of adult FUO cases remain undiagnosed after extensive workup. The syndrome accounts for substantial healthcare utilization, prolonged hospitalizations, and increased morbidity, underscoring the need for evidence-based diagnostic and management strategies.

Pathophysiology

Fever is a regulated physiological response mediated by pyrogenic cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferons. Persistent fever in unresolved inflammatory states reflects ongoing immune activation, often driven by cryptic infections, autoimmune processes, neoplastic infiltration, or granulomatous inflammation. In some cases, dysregulation of the hypothalamic thermoregulatory center or paraneoplastic cytokine release sustains the febrile response. Understanding these mechanisms guides targeted investigations and therapy.

Risk Factors

Risk factors for persistent inflammatory fever include advanced age, immunosuppression (e.g., transplant recipients, HIV/AIDS, long-term corticosteroid use), malignancy, chronic inflammatory or autoimmune diseases, and recent travel or exposure to endemic pathogens. Hospitalized patients, particularly those with indwelling devices, are at higher risk for atypical infections and nosocomial inflammatory syndromes. A thorough history is essential for risk stratification and diagnostic prioritization.

Clinical Features

Patients typically present with fever persisting beyond three weeks, often accompanied by constitutional symptoms such as malaise, weight loss, night sweats, and arthralgia. The absence of localizing signs complicates the clinical picture. Physical examination may reveal subtle clues: lymphadenopathy, hepatosplenomegaly, skin lesions, or joint swelling. Recurrent patterns of fever, such as quotidian or relapsing, may suggest specific etiologies (e.g., adult-onset Still’s disease, periodic fever syndromes). Systematic documentation of symptom chronology is critical in case-based analysis.

Diagnosis

The diagnostic approach to unresolved inflammatory fever is stepwise: initial evaluation excludes common infections, malignancies, and connective tissue diseases. Laboratory workup includes complete blood count, inflammatory markers (ESR, CRP), cultures, serologies, autoantibody panels, and imaging (chest X-ray, abdominal ultrasound). Advanced diagnostics—such as PET-CT, bone marrow biopsy, and molecular testing—are reserved for unresolved cases. Case-based learning highlights the importance of re-evaluating history, repeating examinations, and avoiding premature diagnostic closure. Recent evidence supports the use of FDG-PET/CT in identifying occult inflammatory foci with high sensitivity, especially in vasculitis and neoplastic fever.

Treatment & Management

Management is etiology-specific when a diagnosis is established. For unresolved cases, supportive care, symptomatic antipyretics, and empirical therapy may be considered after exclusion of contraindications. Empirical antibiotics are discouraged without microbiological evidence; inappropriate use may obscure diagnosis and foster resistance. Non-infectious inflammatory fevers may require corticosteroids, immunosuppressants, or biologics based on clinical suspicion and risk-benefit analysis. Multidisciplinary collaboration and ongoing reassessment remain pillars of effective care.

Recent Advances / Emerging Therapies

Recent advances in molecular diagnostics, such as metagenomic next-generation sequencing, have improved the detection of atypical and rare pathogens in persistent fever. The application of targeted biologic agents (e.g., IL-1, IL-6 inhibitors) has revolutionized the management of refractory autoinflammatory syndromes. Biomarker-driven approaches, including procalcitonin and ferritin profiling, aid in differentiating infectious from non-infectious etiologies. Artificial intelligence-assisted pattern recognition and decision support tools are emerging as adjuncts in complex diagnostic algorithms, offering promise for earlier resolution and improved outcomes.

Guideline Recommendations

Major guidelines advocate a structured, tiered approach to persistent fever, emphasizing thorough history-taking, physical examination, and judicious use of laboratory and imaging modalities. The Infectious Diseases Society of America (IDSA) recommends reserving empirical therapy for critically ill patients or those at high risk for rapid deterioration. Early involvement of subspecialists infectious diseases, rheumatology, oncology is endorsed for unresolved cases. Repeated re-evaluation and avoidance of unnecessary interventions are key to minimizing iatrogenic harm.

Conclusion

Persistent fever with unresolved inflammatory etiology remains a diagnostic and therapeutic challenge requiring a systematic, case-based approach. Advances in diagnostic technology, multidisciplinary collaboration, and guideline-directed care have improved outcomes but unresolved cases persist. Ongoing research into novel biomarkers, molecular diagnostics, and targeted therapies holds promise for future progress. Case-based learning continues to be an invaluable strategy for honing clinical reasoning and optimizing patient care in this complex arena.